NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Monod Bio

Monod Bio

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://monod.bio/

Last Round

Grant

Oct 15, 2025

Total Funding Raised

$27.25M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Monod Bio is a biotechnology company that develops AI-powered de novo protein binders and biosensors for research and diagnostic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

de novo proteinbiosensorsprotein designAI-driven protein designin silico protein designmolecular biosensorsrecombinant proteinsluciferasediagnostic reagentsin vitro diagnosticsIVDresearch use onlyRUOprotein engineeringsynthetic biologysynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Monod Bio Comparables

Compare Monod Bio with similar companies based on industry and business-model similarity.

Monod Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tierra Biosciences
70%
A-Alpha Bio
64%
Gator Bio
63%

Monod Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 15, 2025
GrantSep 3, 2025
SeedAug 15, 2022

Key People

Founding team and executive leadership

Daniel-Adriano S.

CEO And President

Executive Team

Monod Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 26, 2026

    Robert J. Bujarski appointed to the Board of Directors.

  • Dec 3, 2025

    Integrated with Gator Bio for next-generation biosensing capabilities.

Monod Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Monod Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Monod Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range27
Year Founded2021
Last FundingOct 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.